Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease.
Adelman
A
A
Pennsylvania State University College of Medicine, Hershey, USA. aadelman@psghs.edu
D000208:Acute Disease; D000284:Administration, Oral; D019317:Evidence-Based Medicine; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007275:Injections, Intravenous; D007902:Length of Stay; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014728:Veterans
D005938:Glucocorticoids; D008775:Methylprednisolone